Follow-up: Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public company The public market is bullish on Adaptive Biotechnologies. The biotech company started trading on the… Read More
Adaptive Biotechnologies has raised the price for its initial public offering, putting itself in a position to raise more cash than any other biotech IPO this year. The Seattle-based company,… Read More
Funko, the Everett, Wash. maker of the popular Pop! figures, set the stock price for its initial public offering Wednesday at $12 per share, lower than its estimated range of… Read More
Snapchat parent Snap Inc. officially filed its initial public offering on Thursday, planning to raise up to $3 billion, ahead of what is widely expected to be one of the… Read More
Nearly 100 tech companies went public in 2016, despite the number of overall exits going down, according to CB Insights. The company’s 2016 Global Tech Exits Report, released Tuesday, found… Read More
Trading on the NASDAQ under the ticker IMDZ, Seattle biotech company Immune Design today priced its initial public offering at $12 per share and raised $60 million. The company, which is… Read More
If you thought 2013 was a good year for tech IPOs, well, 2014 could get a lot more interesting. A new study from CB Insights has identified 590 venture capital and private… Read More